Download PDF
Semin Musculoskelet Radiol 2010; 14(1): 022-036
DOI: 10.1055/s-0030-1248703
© Thieme Medical Publishers

Whole-Body Magnetic Resonance Imaging: Assessment of Skeletal Metastases

Michael R. Moynagh1 , Gabrielle C. Colleran1 , Katarina Tavernaraki2 , Stephen J. Eustace1 , 2 , 3 , Eoin C. Kavanagh1 , 2
  • 1Department of Radiology, Mater Misericordiae University Hospital, Dublin, Ireland
  • 2Department of Radiology, Cappagh National Orthopaedic Hospital, Finglas, Dublin, Ireland
  • 3Department of Radiology, University College Dublin, Dublin, Ireland
Further Information

Publication History

Publication Date:
12 March 2010 (online)

Also available at
    Permissions and Reprints

ABSTRACT

The concept of a rapid whole-body imaging technique with high resolution and the absence of ionizing radiation for the assessment of osseous metastatic disease is a desirable tool. This review article outlines the current perspective of whole-body magnetic resonance imaging in the assessment of skeletal metastatic disease, with comparisons made to alternative whole-body imaging modalities.

KEYWORDS

WBMRI - scintigraphy - computed tomography - skeletal metastases

REFERENCES

  • 1 Imamura F, Kuriyama K, Seto T et al.. Detection of bone marrow metastases of small cell lung cancer with magnetic resonance imaging: early diagnosis before destruction of osseous structure and implications for staging.  Lung Cancer. 2000;  27(3) 189-197
    CrossrefPubMedGoogle Scholar
  • 2 Damadian R. Tumor detection by nuclear magnetic resonance.  Science. 1971;  171(976) 1151-1153
    CrossrefPubMedGoogle Scholar
  • 3 Lauterbur P C. Image formation by induced local interactions: examples employing nuclear magnetic resonance.  Nature. 1973;  242(5394) 190-191
    CrossrefPubMedGoogle Scholar
  • 4 Thrall J H, Ellis B I. Skeletal metastases.  Radiol Clin North Am. 1987;  25(6) 1155-1170
    PubMedGoogle Scholar
  • 5 Ghanem N, Uhl M, Brink I et al.. Diagnostic value of MRI in comparison to scintigraphy, PET, MS-CT and PET/CT for the detection of metastases of bone.  Eur J Radiol. 2005;  55(1) 41-55
    CrossrefPubMedGoogle Scholar
  • 6 Abrams H L, Spiro R, Goldstein N. Metastases in carcinoma; analysis of 1000 autopsied cases.  Cancer. 1950;  3(1) 74-85
    CrossrefPubMedGoogle Scholar
  • 7 Altehoefer C, Ghanem N, Högerle S, Moser E, Langer M. Comparative detectability of bone metastases and impact on therapy of magnetic resonance imaging and bone scintigraphy in patients with breast cancer.  Eur J Radiol. 2001;  40(1) 16-23
    CrossrefPubMedGoogle Scholar
  • 8 Bares R. Skeletal scintigraphy in breast cancer management.  Q J Nucl Med. 1998;  42(1) 43-48
    PubMedGoogle Scholar
  • 9 Hargaden G, O'Connell M, Kavanagh E, Powell T, Ward R, Eustace S. Current concepts in whole-body imaging using turbo short tau inversion recovery MR imaging.  AJR Am J Roentgenol. 2003;  180(1) 247-252
    PubMedGoogle Scholar
  • 10 Lauenstein T C, Freudenberg L S, Goehde S C et al.. Whole-body MRI using a rolling table platform for the detection of bone metastases.  Eur Radiol. 2002;  12(8) 2091-2099
    CrossrefPubMedGoogle Scholar
  • 11 Daffner R H, Lupetin A R, Dash N, Deeb Z L, Sefczek R J, Schapiro R L. MRI in the detection of malignant infiltration of bone marrow.  AJR Am J Roentgenol. 1986;  146(2) 353-358
    PubMedGoogle Scholar
  • 12 Eustace S, Tello R, DeCarvalho V et al.. A comparison of whole-body turboSTIR MR imaging and planar 99mTc-methylene diphosphonate scintigraphy in the examination of patients with suspected skeletal metastases.  AJR Am J Roentgenol. 1997;  169(6) 1655-1661
    PubMedGoogle Scholar
  • 13 Daldrup-Link H E, Franzius C, Link T M et al.. Whole-body MR imaging for detection of bone metastases in children and young adults: comparison with skeletal scintigraphy and FDG PET.  AJR Am J Roentgenol. 2001;  177(1) 229-236
    PubMedGoogle Scholar
  • 14 Engelhard K, Hollenbach H P, Wohlfart K, von Imhoff E, Fellner F A. Comparison of whole-body MRI with automatic moving table technique and bone scintigraphy for screening for bone metastases in patients with breast cancer.  Eur Radiol. 2004;  14(1) 99-105
    CrossrefPubMedGoogle Scholar
  • 15 Mentzel H J, Kentouche K, Sauner D et al.. Comparison of whole-body STIR-MRI and 99mTc-methylene-diphosphonate scintigraphy in children with suspected multifocal bone lesions.  Eur Radiol. 2004;  14(12) 2297-2302
    CrossrefPubMedGoogle Scholar
  • 16 Lauenstein T C, Goehde S C, Herborn C U et al.. Whole-body MR imaging: evaluation of patients for metastases.  Radiology. 2004;  233(1) 139-148
    CrossrefPubMedGoogle Scholar
  • 17 Ghanem N, Altehoefer C, Kelly T et al.. Whole-body MRI in comparison to skeletal scintigraphy in detection of skeletal metastases in patients with solid tumors.  In Vivo. 2006;  20(1) 173-182
    PubMedGoogle Scholar
  • 18 Frat A, Ağildere M, Gençoğlu A et al.. Value of whole-body turbo short tau inversion recovery magnetic resonance imaging with panoramic table for detecting bone metastases: comparison with 99MTc-methylene diphosphonate scintigraphy.  J Comput Assist Tomogr. 2006;  30(1) 151-156
    CrossrefPubMedGoogle Scholar
  • 19 Giraudet A L, Vanel D, Leboulleux S et al.. Imaging medullary thyroid carcinoma with persistent elevated calcitonin levels.  J Clin Endocrinol Metab. 2007;  92(11) 4185-4190
    CrossrefPubMedGoogle Scholar
  • 20 Nakanishi K, Kobayashi M, Takahashi S et al.. Whole body MRI for detecting metastatic bone tumor: comparison with bone scintigrams.  Magn Reson Med Sci. 2005;  4(1) 11-17
    CrossrefPubMedGoogle Scholar
  • 21 Kumar J, Seith A, Kumar A et al.. Whole-body MR imaging with the use of parallel imaging for detection of skeletal metastases in pediatric patients with small-cell neoplasms: comparison with skeletal scintigraphy and FDG PET/CT.  Pediatr Radiol. 2008;  38(9) 953-962
    CrossrefPubMedGoogle Scholar
  • 22 Sohaib S A, Cook G, Allen S D, Hughes M, Eisen T, Gore M. Comparison of whole-body MRI and bone scintigraphy in the detection of bone metastases in renal cancer.  Br J Radiol. 2009;  82(980) 632-639
    CrossrefPubMedGoogle Scholar
  • 23 Schmidt G P, Baur-Melnyk A, Haug A et al.. Whole-body MRI at 1.5 T and 3 T compared with FDG-PET-CT for the detection of tumour recurrence in patients with colorectal cancer.  Eur Radiol. 2009;  19(6) 1366-1378
    CrossrefPubMedGoogle Scholar
  • 24 Takenaka D, Ohno Y, Matsumoto K et al.. Detection of bone metastases in non-small cell lung cancer patients: comparison of whole-body diffusion-weighted imaging (DWI), whole-body MR imaging without and with DWI, whole-body FDG-PET/CT, and bone scintigraphy.  J Magn Reson Imaging. 2009;  30(2) 298-308
    CrossrefPubMedGoogle Scholar
  • 25 Venkitaraman R, Cook G J, Dearnaley D P et al.. Whole-body magnetic resonance imaging in the detection of skeletal metastases in patients with prostate cancer.  J Med Imaging Radiat Oncol. 2009;  53(3) 241-247
    CrossrefPubMedGoogle Scholar
  • 26 Kellenberger C J, Epelman M, Miller S F, Babyn P S. Fast STIR whole-body MR imaging in children.  Radiographics. 2004;  24(5) 1317-1330
    CrossrefPubMedGoogle Scholar
  • 27 Shortt C P, Gleeson T G, Breen K A et al.. Whole-body MRI versus PET in assessment of multiple myeloma disease activity.  AJR Am J Roentgenol. 2009;  192(4) 980-986
    CrossrefPubMedGoogle Scholar
  • 28 El-Khoury G Y, Dalinka M K, Alazraki N et al.. Metastatic bone disease. American College of Radiology. ACR appropriateness criteria.  Radiology. 2000;  215(suppl) 283-293
    PubMedGoogle Scholar
  • 29 Müller-Horvat C, Radny P, Eigentler T K et al.. Prospective comparison of the impact on treatment decisions of whole-body magnetic resonance imaging and computed tomography in patients with metastatic malignant melanoma.  Eur J Cancer. 2006;  42(3) 342-350
    CrossrefPubMedGoogle Scholar
  • 30 Ohno Y, Koyama H, Nogami M et al.. Whole-body MR imaging vs. FDG-PET: comparison of accuracy of M-stage diagnosis for lung cancer patients.  J Magn Reson Imaging. 2007;  26(3) 498-509
    CrossrefPubMedGoogle Scholar
  • 31 Squillaci E, Manenti G, Mancino S et al.. Staging of colon cancer: whole-body MRI vs. whole-body PET-CT—initial clinical experience.  Abdom Imaging. 2008;  33(6) 676-688
    CrossrefPubMedGoogle Scholar
  • 32 Schmidt G P, Baur-Melnyk A, Haug A et al.. Comprehensive imaging of tumor recurrence in breast cancer patients using whole-body MRI at 1.5 and 3 T compared to FDG-PET-CT.  Eur J Radiol. 2008;  65(1) 47-58
    CrossrefPubMedGoogle Scholar
  • 33 Blebea J S, Houseni M, Torigian D A et al.. Structural and functional imaging of normal bone marrow and evaluation of its age-related changes.  Semin Nucl Med. 2007;  37(3) 185-194
    CrossrefPubMedGoogle Scholar
  • 34 Hwang S, Panicek D M. Magnetic resonance imaging of bone marrow in oncology, Part 1.  Skeletal Radiol. 2007;  36(10) 913-920
    CrossrefPubMedGoogle Scholar
  • 35 Walker R, Kessar P, Blanchard R et al.. Turbo STIR magnetic resonance imaging as a whole-body screening tool for metastases in patients with breast carcinoma: preliminary clinical experience.  J Magn Reson Imaging. 2000;  11(4) 343-350
    CrossrefPubMedGoogle Scholar
  • 36 Krishnamurthy G T, Tubis M, Hiss J, Blahd W H. Distribution pattern of metastatic bone disease. A need for total body skeletal image.  JAMA. 1977;  237(23) 2504-2506
    CrossrefPubMedGoogle Scholar
  • 37 Barkhausen J, Quick H H, Lauenstein T et al.. Whole-body MR imaging in 30 seconds with real-time true FISP and a continuously rolling table platform: feasibility study.  Radiology. 2001;  220(1) 252-256
    CrossrefPubMedGoogle Scholar
  • 38 Dwyer A J, Frank J A, Sank V J, Reinig J W, Hickey A M, Doppman J L. Short-Ti inversion-recovery pulse sequence: analysis and initial experience in cancer imaging.  Radiology. 1988;  168(3) 827-836
    PubMedGoogle Scholar
  • 39 Jones K M, Unger E C, Granstrom P, Seeger J F, Carmody R F, Yoshino M. Bone marrow imaging using STIR at 0.5 and 1.5 T.  Magn Reson Imaging. 1992;  10(2) 169-176
    CrossrefPubMedGoogle Scholar
  • 40 Constable R T, Smith R C, Gore J C. Signal-to-noise and contrast in fast spin echo (FSE) and inversion recovery FSE imaging.  J Comput Assist Tomogr. 1992;  16(1) 41-47
    CrossrefPubMedGoogle Scholar
  • 41 Hennig J, Nauerth A, Friedburg H. RARE imaging: a fast imaging method for clinical MR.  Magn Reson Med. 1986;  3(6) 823-833
    CrossrefPubMedGoogle Scholar
  • 42 Vanel D, Bittoun J, Tardivon A. MRI of bone metastases.  Eur Radiol. 1998;  8(8) 1345-1351
    CrossrefPubMedGoogle Scholar
  • 43 Mehta R C, Marks M P, Hinks R S, Glover G H, Enzmann D R. MR evaluation of vertebral metastases: T1-weighted, short-inversion-time inversion recovery, fast spin-echo, and inversion-recovery fast spin-echo sequences.  AJNR Am J Neuroradiol. 1995;  16(2) 281-288
    PubMedGoogle Scholar
  • 44 Hoane B R, Shields A F, Porter B A, Shulman H M. Detection of lymphomatous bone marrow involvement with magnetic resonance imaging.  Blood. 1991;  78(3) 728-738
    PubMedGoogle Scholar
  • 45 Flickinger F W, Sanal S M. Bone marrow MRI: techniques and accuracy for detecting breast cancer metastases.  Magn Reson Imaging. 1994;  12(6) 829-835
    CrossrefPubMedGoogle Scholar
  • 46 Kavanagh E, Smith C, Eustace S. Whole-body turbo STIR MR imaging: controversies and avenues for development.  Eur Radiol. 2003;  13(9) 2196-2205
    CrossrefPubMedGoogle Scholar
  • 47 Steinborn M M, Heuck A F, Tiling R, Bruegel M, Gauger L, Reiser M F. Whole-body bone marrow MRI in patients with metastatic disease to the skeletal system.  J Comput Assist Tomogr. 1999;  23(1) 123-129
    CrossrefPubMedGoogle Scholar
  • 48 O'Connell M J, Hargaden G, Powell T, Eustace S J. Whole-body turbo short tau inversion recovery MR imaging using a moving tabletop.  AJR Am J Roentgenol. 2002;  179(4) 866-868
    PubMedGoogle Scholar
  • 49 Johnston C, Brennan S, Ford S, Eustace S. Whole body MR imaging: applications in oncology.  Eur J Surg Oncol. 2006;  32(3) 239-246
    CrossrefPubMedGoogle Scholar
  • 50 Mazumdar A, Siegel M J, Narra V, Luchtman-Jones L. Whole-body fast inversion recovery MR imaging of small cell neoplasms in pediatric patients: a pilot study.  AJR Am J Roentgenol. 2002;  179(5) 1261-1266
    PubMedGoogle Scholar
  • 51 Baur A, Stäbler A, Bartl R, Lamerz R, Scheidler J, Reiser M. MRI gadolinium enhancement of bone marrow: age-related changes in normals and in diffuse neoplastic infiltration.  Skeletal Radiol. 1997;  26(7) 414-418
    CrossrefPubMedGoogle Scholar
  • 52 Kwee T C, Takahara T, Ochiai R et al.. Whole-body diffusion-weighted magnetic resonance imaging.  Eur J Radiol. 2009;  70(3) 409-417
    CrossrefPubMedGoogle Scholar
  • 53 Edelstyn G A, Gillespie P J, Grebbell F S. The radiological demonstration of osseous metastases. Experimental observations.  Clin Radiol. 1967;  18(2) 158-162
    CrossrefPubMedGoogle Scholar
  • 54 Avrahami E, Tadmor R, Dally O, Hadar H. Early MR demonstration of spinal metastases in patients with normal radiographs and CT and radionuclide bone scans.  J Comput Assist Tomogr. 1989;  13(4) 598-602
    CrossrefPubMedGoogle Scholar
  • 55 Frank J A, Ling A, Patronas N J et al.. Detection of malignant bone tumors: MR imaging vs scintigraphy.  AJR Am J Roentgenol. 1990;  155(5) 1043-1048
    PubMedGoogle Scholar
  • 56 Algra P R, Bloem J L, Tissing H, Falke T H, Arndt J W, Verboom L J. Detection of vertebral metastases: comparison between MR imaging and bone scintigraphy.  Radiographics. 1991;  11(2) 219-232
    PubMedGoogle Scholar
  • 57 Shie P, Cardarelli R, Brandon D, Erdman W, Abdulrahim N. Meta-analysis: comparison of F-18 fluorodeoxyglucose-positron emission tomography and bone scintigraphy in the detection of bone metastases in patients with breast cancer.  Clin Nucl Med. 2008;  33(2) 97-101
    CrossrefPubMedGoogle Scholar
  • 58 Schirrmeister H, Glatting G, Hetzel J et al.. Prospective evaluation of the clinical value of planar bone scans, SPECT, and (18)F-labeled NaF PET in newly diagnosed lung cancer.  J Nucl Med. 2001;  42(12) 1800-1804
    PubMedGoogle Scholar
  • 59 Sedonja I, Budihna N V. The benefit of SPECT when added to planar scintigraphy in patients with bone metastases in the spine.  Clin Nucl Med. 1999;  24(6) 407-413
    CrossrefPubMedGoogle Scholar
  • 60 Roland J, van den Weyngaert D, Krug B, Brans B, Scalliet P, Vandevivere J. Metastases seen on SPECT imaging despite a normal planar bone scan.  Clin Nucl Med. 1995;  20(12) 1052-1054
    CrossrefPubMedGoogle Scholar
  • 61 Savelli G, Maffioli L, Maccauro M, De Deckere E, Bombardieri E. Bone scintigraphy and the added value of SPECT (single photon emission tomography) in detecting skeletal lesions.  Q J Nucl Med. 2001;  45(1) 27-37
    PubMedGoogle Scholar
  • 62 Söderlund V. Radiological diagnosis of skeletal metastases.  Eur Radiol. 1996;  6(5) 587-595
    PubMedGoogle Scholar
  • 63 Layer G, Steudel A, Schüller H et al.. Magnetic resonance imaging to detect bone marrow metastases in the initial staging of small cell lung carcinoma and breast carcinoma.  Cancer. 1999;  85(4) 1004-1009
    CrossrefPubMedGoogle Scholar
  • 64 Khurana J S, Rosenthal D I, Rosenberg A E, Mankin H J. Skeletal metastases in liposarcoma detectable only by magnetic resonance imaging.  Clin Orthop Relat Res. 1989;  (243) 204-207
    PubMedGoogle Scholar
  • 65 Nakanishi K, Kobayashi M, Nakaguchi K et al.. Whole-body MRI for detecting metastatic bone tumor: diagnostic value of diffusion-weighted images.  Magn Reson Med Sci. 2007;  6(3) 147-155
    CrossrefPubMedGoogle Scholar
  • 66 Leboulleux S, Dromain C, Vataire A L et al.. Prediction and diagnosis of bone metastases in well-differentiated gastro-entero-pancreatic endocrine cancer: a prospective comparison of whole body magnetic resonance imaging and somatostatin receptor scintigraphy.  J Clin Endocrinol Metab. 2008;  93(8) 3021-3028
    CrossrefPubMedGoogle Scholar
  • 67 Yamaguchi T. Intertrabecular vertebral metastases: metastases only detectable on MR imaging.  Semin Musculoskelet Radiol. 2001;  5(2) 171-175
    Article in Thieme ConnectPubMedGoogle Scholar
  • 68 Smith R C, Reinhold C, Lange R C, McCauley T R, Kier R, McCarthy S. Fast spin-echo MR imaging of the female pelvis. Part I. Use of a whole-volume coil.  Radiology. 1992;  184(3) 665-669
    PubMedGoogle Scholar
  • 69 Fleckenstein J L, Archer B T, Barker B A, Vaughan J T, Parkey R W, Peshock R M. Fast short-tau inversion-recovery MR imaging.  Radiology. 1991;  179(2) 499-504
    PubMedGoogle Scholar
  • 70 Bydder G M, Hajnal J V, Young I R. MRI: use of the inversion recovery pulse sequence.  Clin Radiol. 1998;  53(3) 159-176
    CrossrefPubMedGoogle Scholar
  • 71 Buhmann Kirchhoff S, Becker C, Duerr H R, Reiser M, Baur-Melnyk A. Detection of osseous metastases of the spine: comparison of high resolution multi-detector-CT with MRI.  Eur J Radiol. 2009;  69(3) 567-573
    CrossrefPubMedGoogle Scholar
  • 72 Pfannenberg C, Aschoff P, Schanz S et al.. Prospective comparison of 18F-fluorodeoxyglucose positron emission tomography/computed tomography and whole-body magnetic resonance imaging in staging of advanced malignant melanoma.  Eur J Cancer. 2007;  43(3) 557-564
    CrossrefPubMedGoogle Scholar
  • 73 Phelps M E. PET: the merging of biology and imaging into molecular imaging.  J Nucl Med. 2000;  41(4) 661-681
    PubMedGoogle Scholar
  • 74 Schmidt G P, Haug A R, Schoenberg S O, Reiser M F. Whole-body MRI and PET-CT in the management of cancer patients.  Eur Radiol. 2006;  16(6) 1216-1225
    CrossrefPubMedGoogle Scholar
  • 75 Brix G, Lechel U, Glatting G et al.. Radiation exposure of patients undergoing whole-body dual-modality 18F-FDG PET/CT examinations.  J Nucl Med. 2005;  46(4) 608-613
    PubMedGoogle Scholar
  • 76 Cook G JR. Skeletal metastases: what is the future role for nuclear medicine?.  Eur J Nucl Med Mol Imaging. 2009;  36(11) 1803-1806
    CrossrefPubMedGoogle Scholar
  • 77 Israel O, Goldberg A, Nachtigal A et al.. FDG-PET and CT patterns of bone metastases and their relationship to previously administered anti-cancer therapy.  Eur J Nucl Med Mol Imaging. 2006;  33(11) 1280-1284
    CrossrefPubMedGoogle Scholar
  • 78 Schmidt G P, Schoenberg S O, Schmid R et al.. Screening for bone metastases: whole-body MRI using a 32-channel system versus dual-modality PET-CT.  Eur Radiol. 2007;  17(4) 939-949
    CrossrefPubMedGoogle Scholar
  • 79 Antoch G, Vogt F M, Freudenberg L S et al.. Whole-body dual-modality PET/CT and whole-body MRI for tumor staging in oncology.  JAMA. 2003;  290(24) 3199-3206
    CrossrefPubMedGoogle Scholar

Michael MoynaghB.Sc. 

Department of Radiology

Mater Misericordiae University Hospital, Eccles St., Dublin 7, Ireland

Email: Michaelmoynagh@gmail.com

      >